Taiwo Ajani
Psychiatric/Mental Health · Laurel, MDNPI 1982170213
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,837, 3.7 times the $500 reported in 2022. Among psychiatric/mental health clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 121 payments — averaging $34.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$771
- AbbVie$754
- Axsome Therapeutics, Inc.$423
- Supernus Pharmaceuticals, Inc.$329
- Alkermes, Inc.$284
- Biogen$251
- plus $1K from 13 others
What the payments were for
- Food & beverage$4,215100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $771 |
| AbbVie | 25 | $754 |
| Axsome Therapeutics, Inc. | 11 | $423 |
| Supernus Pharmaceuticals, Inc. | 20 | $329 |
| Alkermes, Inc. | 13 | $284 |
| Biogen | 4 | $251 |
| Vifor Pharma, Inc. | 2 | $234 |
| Neuronetics, Inc. | 4 | $184 |
| Otsuka America Pharmaceutical, Inc. | 2 | $153 |
| Angiodynamics, Inc. | 1 | $140 |
| E.r. Squibb & Sons, L.L.C. | 2 | $140 |
| Johnson & Johnson | 1 | $138 |
| Corium, LLC | 1 | $115 |
| Neurocrine Biosciences, Inc. | 1 | $114 |
| Janssen Products, LP | 1 | $102 |
| Fresenius USA Marketing, Inc. | 2 | $30 |
| Lundbeck LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Akebia Therapeutics Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,219 in reported general payments places this provider in the 90th percentile of 1,461 psychiatric/mental health providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buspirone Hcl | 11 | $66 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Laurel
- Florence NwanaLaurel$7K
- Hara OyedejiOwings Mills$780K
- Ilya RozenbergGlen Burnie$572K
- Michelle WilliamsColumbia$158K
- Kristin ClemensGaithersburg$36K
- Antonio HeroldHavre de Grace$23K
- Paul KlaverweidenFruitland$17K
- Margaret WebbAberdeen$16K
- Susan KrausTowson$16K
- Anyinke AtabongRockville$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.